(Q78424586)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12399191%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

title

The immunogenicity and reactogenicity profile of a candidate hepatitis B vaccine in an adult vaccine non-responder population (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12399191%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

1 reference

1 reference

1 reference

P Jacques

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12399191%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

G Moens

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12399191%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

I Desombere

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12399191%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

J Dewijngaert

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12399191%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

G Leroux-Roels

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12399191%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

M Wettendorff

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12399191%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

S Thoelen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12399191%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

publication date

1 November 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12399191%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12399191%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12399191%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

page(s)

3644-3649

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12399191%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

issue

31-32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12399191%20AND%20SRC:MED&resulttype=core&format=json

Global programme for control of hepatitis B infection

14 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900397-3

7 January 2021

Recombinant hepatitis B vaccine: a review of its immunogenicity and protective efficacy against hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900397-3

7 January 2021

Over a decade of experience with a yeast recombinant hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900397-3

7 January 2021

Hepatitis B vaccination in mentally retarded: Effectiveness after 11 years1To whom it may concern I declare that the parents (guardian) of all subjects have given informed consent and that the study was approved by the ethical committee of the Univer

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900397-3

7 January 2021

Hepatitis B vaccines: assessment of the seroprotective efficacy of two recombinant DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900397-3

7 January 2021

Nonresponse to hepatitis B vaccines and the kinetics of anti-HBs production

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900397-3

7 January 2021

Response to hepatitis B vaccine: multiple HLA genes are involved.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900397-3

7 January 2021

Safety and immunogenicity of a hepatitis B vaccine formulated with a novel adjuvant system

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900397-3

7 January 2021

A hepatitis B vaccine formulated with a novel adjuvant system

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900397-3

7 January 2021

Rapid DNA typing of class II HLA antigens using the polymerase chain reaction and reverse dot blot hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900397-3

7 January 2021

Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900397-3

7 January 2021

Booster immunization of low- and non-responders after a standard three dose hepatitis B vaccine schedule--results of a post-marketing surveillance.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900397-3

7 January 2021

Randomized, comparative trial of 20 micrograms vs 40 micrograms Engerix B vaccine in hepatitis B vaccine non-responders.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900397-3

7 January 2021

Contribution of human leukocyte antigens to the antibody response to hepatitis B vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900397-3

7 January 2021

Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memory

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900397-3

7 January 2021

10.1016/S0264-410X(02)00397-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12399191%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

1 reference